Skip to main content
DNA Labs India

CYLD Gene Trichoepithelioma, multiple familial, type 1 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

CYLD Gene Trichoepithelioma, multiple familial, type 1 NGS Genetic Test

Short Name: CYLD NGS Test

Also known as: CYLD gene mutation test, Trichoepithelioma genetic panel, MFT1 NGS test

CYLD Gene Trichoepithelioma, multiple familial, type 1 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Results are typically available within 3 to 4 weeks after the sample reaches the laboratory. You will be notified via email or phone when the report is ready.. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

The primary purpose of this test is to confirm a clinical diagnosis of multiple familial trichoepithelioma type 1 by identifying pathogenic mutations in the CYLD gene. It is also used for predictive testing in asymptomatic family members of affected individuals, enabling early surveillance and management. Additionally, the test aids in genetic counseling by providing accurate recurrence risk information for family planning.

Test Code
6028
CPT Code
81479
ICD Code
Q82.8
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Results are typically available within 3 to 4 weeks after the sample reaches the laboratory. You will be notified via email or phone when the report is ready.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation is required. However, a genetic counseling session is recommended prior to testing to discuss the implications of the results. Please inform the lab if you have had a blood transfusion in the past 3 months.

Method: Venipuncture or finger prick

Step 2

Laboratory Analysis

Blood sample will be collected by a trained phlebotomist using sterile techniques. For FTA card, a simple finger prick will be performed. The procedure is quick and minimally invasive.

Step 3

Report Delivery

No specific aftercare is needed. You can resume normal activities immediately. The sample will be transported to the laboratory for analysis.

Timeline: Results are typically available within 3 to 4 weeks after the sample reaches the laboratory. You will be notified via email or phone when the report is ready.

Patient Instructions

1
Before the Test:Before undergoing the CYLD gene NGS test, it is important to have a genetic counseling session to understand the purpose, risks, benefits, and potential outcomes of the test. Discuss your family history and any concerns with your healthcare provider.
2
During the Test:The test involves a simple blood draw or finger prick for FTA card. No special measures are required. You may feel a slight prick during blood collection.
3
After the Test:After the test, you can resume normal activities. Results will be available in 3-4 weeks. Your healthcare provider will discuss the results and their implications with you.

About This Test

Who Should Get This Test

The primary purpose of this test is to confirm a clinical diagnosis of multiple familial trichoepithelioma type 1 by identifying pathogenic mutations in the CYLD gene. It is also used for predictive testing in asymptomatic family members of affected individuals, enabling early surveillance and management. Additionally, the test aids in genetic counseling by providing accurate recurrence risk information for family planning.

How to Prepare

  • Ensure the sample is labeled correctly with patient details.
  • For blood sample, use EDTA vacutainer and mix gently to prevent clotting.
  • For FTA card, apply one drop of blood onto the designated circle and allow to air dry.
  • Store sample at room temperature (15-30°C) until shipment.
  • Ship the sample to the lab within 24-48 hours of collection.

Doctor's Notes

Reviewed by — MBBS, MD (General Medicine) · Reg. No. 8052

"Genetic testing for CYLD mutations is crucial for confirming MFT1 diagnosis and guiding family screening. Early detection allows for proactive management of skin lesions and surveillance for potential complications."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume2-3 ml blood or 1 drop on FTA card
ContainerEDTA vacutainer or FTA card
Collection MethodVenipuncture or finger prick

Sample Stability

Blood in EDTA48 hours
Blood in EDTA7 days
Extracted DNA6 months
FTA card1 year
Sample Rejection Criteria:
  • Hemolyzed or clotted blood sample
  • Insufficient sample volume
  • Incorrect labeling
  • Sample received after prolonged storage (>7 days at room temperature)
  • Sample exposed to extreme temperatures

Understanding Your Results

The interpretation of CYLD gene NGS results should be performed by a qualified geneticist or medical professional. Results are reported as positive, negative, or variant of uncertain significance (VUS).
📊

Positive (Pathogenic variant detected)

Confirms diagnosis of MFT1. Autosomal dominant inheritance. Family members at risk should be offered testing. Clinical surveillance for skin lesions and other CYLD-related manifestations is recommended.

📊

Negative (No pathogenic variant detected)

Does not rule out MFT1 if clinical suspicion is high. Other genetic causes may be considered. Further testing or clinical evaluation may be needed.

📊

Variant of Uncertain Significance (VUS)

A genetic variant was found but its clinical significance is unknown. Additional family studies or functional assays may help clarify. Genetic counseling is advised.

⚠️ When to Consult a Doctor:

Consult a dermatologist or geneticist if you have multiple skin bumps on the face or upper body, especially if they are increasing in number or size, or if you have a family history of trichoepithelioma. Also, seek medical advice if you experience bleeding, itching, or cosmetic concerns from the lesions.

Limitations

  • This test only analyzes the CYLD gene; mutations in other genes (e.g., CYLD-related syndromes) may not be detected.
  • NGS may not detect all types of mutations (e.g., deep intronic variants, large structural rearrangements) – additional testing may be required.
  • Variant of uncertain significance (VUS) results may require further family studies.
  • Test does not predict severity or age of onset of symptoms.
  • Genetic testing should be accompanied by genetic counseling.

Risks & Considerations

  • Minimal risk of bruising or infection at the blood draw site
  • Psychological impact of genetic test results
  • Potential for incidental findings (unrelated genetic variants)
  • Risk of genetic discrimination (though limited by laws in some countries)

Interfering Factors

  • Contaminated or degraded DNA sample
  • Insufficient sample quantity
  • Presence of maternal cell contamination (if prenatal)
  • Recent blood transfusion (may dilute DNA)
  • Certain medications that affect DNA quality (rare)

Compare With Similar Tests

TestCYLD Gene Trichoepithelioma, multiple familial, type 1 NGS Genetic TestCYLD Gene Sequencing (Sanger)Skin Tumor Panel (NGS)Whole Exome Sequencing
ComparisonCYLD Gene Trichoepithelioma, multiple familial, type 1 NGS Genetic Test

Frequently Asked Questions

What is multiple familial trichoepithelioma type 1 (MFT1)?
MFT1 is a rare genetic disorder characterized by multiple benign skin tumors (trichoepitheliomas) arising from hair follicles. It is inherited in an autosomal dominant pattern and is caused by mutations in the CYLD gene.
How is the CYLD gene NGS test performed?
The test uses Next-Generation Sequencing to analyze the CYLD gene for mutations. A blood sample or FTA card blood spot is collected and sent to the laboratory. The DNA is extracted, sequenced, and analyzed for pathogenic variants.
What is the cost of the CYLD gene NGS test?
The test costs INR 20000 at DNA Labs India. This includes free home sample collection, genetic counseling, and a detailed report.
Who should consider this genetic test?
Individuals with clinical features of trichoepithelioma, a family history of MFT1, or those seeking predictive testing for at-risk relatives should consider this test. It is also useful for differential diagnosis of skin tumor syndromes.
What does a positive result mean?
A positive result indicates the presence of a pathogenic mutation in the CYLD gene, confirming the diagnosis of MFT1. It also implies a 50% risk of passing the mutation to offspring.
What does a negative result mean?
A negative result means no pathogenic mutation was detected in the CYLD gene. However, it does not completely rule out MFT1, as other genetic or non-genetic causes may be responsible.
What is a variant of uncertain significance (VUS)?
A VUS is a genetic variant whose impact on health is unknown. Further testing of family members or additional research may help determine its significance. Genetic counseling is recommended.
Is fasting required before the test?
No, fasting is not required for this genetic test. You can eat and drink normally before sample collection.
What sample types are accepted?
We accept blood (EDTA), extracted DNA, or one drop of blood on an FTA card. The sample type can be chosen based on convenience.
How long does it take to get results?
Results are typically available within 3 to 4 weeks after the sample is received at the laboratory.
Is home sample collection available?
Yes, DNA Labs India offers free home sample collection for this test across major cities in India. You can book online and a phlebotomist will visit your location.
Will insurance cover this test?
Insurance coverage varies. Some private insurance plans may cover genetic testing if medically necessary. We recommend checking with your insurance provider. We also offer a discounted price of INR 20000.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.